Organon & Co.
OGN · NYSE
Bulios Fair Price
$10.55
22.8% downside
Trenutna cena
$13.67
Po podatkih Bulios Fair Price je delnica OGN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Organon & Co. (OGN) is an international pharmaceutical company specializing in the research, development, and production of medicinal products and medical use products. The company focuses on a wide range of therapeutic areas, including women's health, neurology, cardiology, endocrinology, and others. Organon & Co. provides medicines and treatment options for patients with various health needs, contributes to the development of new drugs and innovative treatment procedures. The company emphasizes the high quality, safety, and effectiveness of its products and is dedicated to improving the health and quality of life of patients. Organon & Co. collaborates with medical professionals, research institutions, and healthcare organizations worldwide. Shares of Organon & Co. represent an intriguing investment opportunity for those who believe in the prospects of the pharmaceutical industry and its contributions to human health.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joseph T. Morrissey Jr.
Employees
10,000
Headquarters
Jersey City
Prihajajoči dogodki
Earnings
Upcoming earnings report